Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.60 |
| ▸ | NPC1 | O15118 | 2/20 | 0.56 |
| ▸ | RAB9A | P51151 | 2/20 | 0.56 |
| ▸ | ANPEP | P15144 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7387341 | 1.00 | POLB (0.60) | POLBNPC1RAB9AANPEPL3MBTL1 | |
| SCHEMBL6446955 | 0.90 | NPC1 (0.58) | POLBNPC1RAB9AL3MBTL1ALDH1A1 | |
| SCHEMBL6446960 | 0.90 | NPC1 (0.58) | POLBNPC1RAB9AL3MBTL1ALDH1A1 | |
| SCHEMBL7427282 | 0.83 | KEAP1 (0.48) | POLBANPEPALDH1A1SMN1; SMN2CYP1A2 | |
| SCHEMBL7799019 | 0.82 | POLB (0.60) | POLBNPC1RAB9AL3MBTL1ALDH1A1 | |
| SCHEMBL7799015 | 0.82 | POLB (0.60) | POLBNPC1RAB9AL3MBTL1ALDH1A1 | |
| SCHEMBL12826770 | 0.81 | POLB (0.57) | POLBNPC1RAB9AL3MBTL1ALDH1A1 | |
| SCHEMBL7310554 | 0.80 | RAB9A (0.55) | POLBNPC1RAB9ASMN1; SMN2CYP2D6 | |
| SCHEMBL7310548 | 0.80 | RAB9A (0.55) | POLBNPC1RAB9ASMN1; SMN2CYP2D6 | |
| SCHEMBL7415049 | 0.80 | ALDH1A1 (0.60) | POLBNPC1RAB9AL3MBTL1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0575097-B1 | 2,3-Bis-carboxamidomethyl substituted oxiranes as inhibitors of HIV protease and their use for the treatment of AIDS | LILLY CO ELI (US) | 2000-11-02 | — | — | EP | disclosed |